Cargando…
Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults
BACKGROUND: This phase III clinical trial compared the immunogenicity and safety of a purified chick-embryo cell rabies vaccine (PCECV) administered according to a shortened post-exposure prophylaxis (PEP) 4-site/1-week intradermal regimen, compared with the currently recommended 2-site/Thai Red Cro...
Autores principales: | Kerdpanich, Phirangkul, Chanthavanich, Pornthep, De Los Reyes, Mari Rose, Lim, Jodor, Yu, Delia, Ama, Ma. Cecilia, Mojares, Zenaida, Casula, Daniela, Arora, Ashwani Kumar, Pellegrini, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005579/ https://www.ncbi.nlm.nih.gov/pubmed/29874228 http://dx.doi.org/10.1371/journal.pntd.0006340 |
Ejemplares similares
-
Simplification of Rabies Postexposure Prophylaxis: A New 2-Visit Intradermal Vaccine Regimen
por: Warrell, Mary J.
Publicado: (2019) -
Side-by-side Comparative Study of the Immunogenicity of the Intramuscular and Intradermal Rabies Post-exposure Prophylaxis Regimens in a Cohort of Suspected Rabies Virus Exposed Individuals
por: Auerswald, Heidi, et al.
Publicado: (2023) -
Safety and Immunogenicity of MF59-Adjuvanted Cell Culture–Derived A/H5N1 Subunit Influenza Virus Vaccine: Dose-Finding Clinical Trials in Adults and the Elderly
por: Frey, Sharon E, et al.
Publicado: (2019) -
Modelling to inform prophylaxis regimens to prevent human rabies
por: Hampson, Katie, et al.
Publicado: (2019) -
A shorter post-exposure prophylaxis regimen for rabies, Pakistan
por: Salahuddin, Naseem, et al.
Publicado: (2021)